Statistical Considerations for Clinical Trials During COVID-19 Final
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency - Conduct-of-Clinical Trial-During-COVID-19-QA Updated 05.14.20.pdf
US EPA - Guidance for Waiving Acute Dermal Toxicity Tests for Pesticide Formulations & Supporting Retrospective Analysis
Federal Register :: Draft Guidance for Waiving Acute Dermal Toxicity Tests for Pesticide Technical Chemicals and Supporting Retrospective Analysis ***Request for Comment
2020. EPA is announcing the availability of and seeking public comment on a draft guidance document